Eclipse and Mayo Clinic create Nucleus RadioPharma to better serve cancer patients

Nucleus RadioPharma is developing technologies to usher in a new era in radiopharmaceutical development, supply chain and manufacturing ROCHESTER, Minn., and PALO ALTO, Calif. — Eclipse, a venture capital firm investing in the digital transformation of the world's physical industries, and Mayo Clinic today announced the creation and seed funding of Nucleus RadioPharma, a new company built to ensure cancer patients can access potentially lifesaving radiopharmaceuticals b y developing technologies to modernize the clinical development, manufacturing…
Source: Mayo Clinic Business News - Category: Pharmaceuticals Source Type: news